Rick Dewey

Dr Rick Dewey

Senior Director, Head of Translational Genetics, Regeneron

Frederick Dewey received his AB in Chemistry and Physics from Harvard University, and MD, with concentration in cardiovascular and pulmonary sciences, from Stanford University. He received clinical training in internal medicine and cardiovascular medicine, and research training in human genetics at Stanford Hospital and Clinics. He joined the Regeneron Genetics Center, a wholly-owned subsidiary of Regeneron Pharmaceuticals, in 2014 and is currently Senior Director and Head of the Translational Genetics group, which uses large scale sequencing to identify and validate therapeutic targets.


Featured Speakers


The event is a good opportunity for industry to come together and identify ways to understand and utilize big data in the advancement of patient care.

Dr Mark Roche, CEO, Avanti iHealth

Show the sponsors

Vote who is making waves in the industry!

Phacilitate will gather influencers and industry innovators together from across healthcare, academia, Big Pharma, government and technology innovators into an ebook. Find out more